• LAST PRICE
    6.7000
  • TODAY'S CHANGE (%)
    Trending Down-0.1300 (-1.9034%)
  • Bid / Lots
    6.7000/ 7
  • Ask / Lots
    6.7100/ 10
  • Open / Previous Close
    6.7500 / 6.8300
  • Day Range
    Low 6.5200
    High 6.8550
  • 52 Week Range
    Low 2.8650
    High 25.3900
  • Volume
    2,826,514
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 6.83
TimeVolumeBLUE
09:32 ET1162876.64
09:34 ET736756.68
09:36 ET281096.669
09:38 ET259246.61
09:39 ET244176.6288
09:41 ET386096.61
09:43 ET350116.6597
09:45 ET405116.675
09:48 ET252956.63
09:50 ET123946.6199
09:52 ET207756.635
09:54 ET217916.78
09:56 ET1016116.81
09:57 ET107116.71
09:59 ET175526.66
10:01 ET294866.631
10:03 ET268336.645
10:06 ET183996.7
10:08 ET109476.69
10:10 ET113996.661
10:12 ET137226.7
10:14 ET219516.675
10:15 ET367916.705
10:17 ET121946.7192
10:19 ET2196146.71
10:21 ET172686.64
10:24 ET522916.59
10:26 ET303336.5641
10:28 ET259236.57
10:30 ET141156.58
10:32 ET349356.5441
10:33 ET229576.5599
10:35 ET495626.5398
10:37 ET150916.565
10:39 ET185026.58
10:42 ET191736.6125
10:44 ET87426.65
10:46 ET203976.635
10:48 ET72516.6497
10:50 ET219286.65
10:51 ET434246.6384
10:53 ET425326.62
10:55 ET454966.575
10:57 ET512876.5585
11:00 ET120176.55
11:02 ET80396.5699
11:04 ET176846.5258
11:06 ET194916.555
11:08 ET76196.5697
11:09 ET347146.555
11:11 ET131216.5877
11:13 ET172846.585
11:15 ET199766.615
11:18 ET931866.67
11:20 ET166706.655
11:22 ET161086.66
11:24 ET134466.66
11:26 ET82996.685
11:27 ET259276.705
11:29 ET58116.71
11:31 ET100006.725
11:33 ET173116.7
11:36 ET92296.71
11:38 ET66266.695
11:40 ET364186.72
11:42 ET112286.7
11:44 ET121556.7
11:45 ET161156.685
11:47 ET191626.705
11:49 ET218216.69
11:51 ET79456.6507
11:54 ET107376.66
11:56 ET77236.64
11:58 ET168786.655
12:00 ET84006.7
12:02 ET142146.72
12:03 ET256766.75
12:05 ET133606.7375
12:07 ET15506.7446
12:09 ET106896.7392
12:12 ET76236.75
12:14 ET195376.7476
12:16 ET159896.77
12:18 ET118746.785
12:20 ET119606.795
12:21 ET255796.7909
12:23 ET635916.83
12:25 ET327136.83
12:27 ET164366.8
12:30 ET215636.745
12:32 ET70736.75
12:34 ET79796.77
12:36 ET116006.74
12:38 ET57926.755
12:39 ET105026.76
12:41 ET132006.77
12:43 ET213006.73
12:45 ET133066.69
12:48 ET179506.71
12:50 ET59776.7
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBLUE
bluebird bio Inc
457.3M
-0.9x
---
United StatesBTAI
BioXcel Therapeutics Inc
419.8M
-3.7x
---
United StatesADGI
Adagio Therapeutics Inc
436.8M
-1.2x
---
United StatesRGC
Regencell Bioscience Holdings Ltd
421.6M
-291.0x
---
United StatesALDX
Aldeyra Therapeutics Inc
451.4M
-6.6x
---
United StatesHLVX
Hillevax Inc
432.9M
-2.6x
---
As of 2022-08-16

Company Information

bluebird bio, Inc. is a biotechnology company. The Company is principally focused on researching, developing and commercializing gene therapies for genetic diseases. The Company’s gene therapy programs in genetic diseases include programs for B-thalassemia; LentiGlobin product candidate as a treatment for sickle cell disease (SCD), and elivaldogene autotemcel (eli-cel) as a treatment for cerebral adrenoleukodystrophy (CALD). It is using a lentiviral vector (LVV) platform, it custom designs each of its therapies to address the underlying cause of disease. The Company is developing lovotibeglogene autotemcel (lovo-cel) as a one-time treatment for patients with SCD, a genetic disease caused by a single mutation in the B-globin gene that leads to the production of abnormal sickle hemoglobin (HbS). The BLA for betibeglogene autotemcel (beti-cel) is for B-thalassemia in patients who receive regular red blood cell (RBC) transfusions.

Contact Information

Headquarters
455 Grand Union BoulevardSOMERVILLE, MA, United States 02145
Phone
339-499-9300
Fax
302-636-5454

Executives

President, Chief Executive Officer, Director
Andrew Obenshain
Chief Business Officer, Chief Strategy and Financial Officer
Jason Cole
Chief Commercial and Operating Officer
Thomas Klima
Chief Regulatory Officer
Anne-Virginie Eggimann
Independent Director
John Agwunobi

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$457.3M
Revenue (TTM)
$6.1M
Shares Outstanding
77.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.36
EPS
$-7.05
Book Value
$5.26
P/E Ratio
-0.9x
Price/Sales (TTM)
75.1
Price/Cash Flow (TTM)
---
Operating Margin
-8,504.88%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.